NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

A DOAC Deep Dive: Rivaroxaban

For the past several decades, warfarin has been the go-to anticoagulant for doctors, but new treatments have recently emerged in…